Quick Takeaways
- Zhenfeng M. Chen filed SCHEDULE 13G for CASI Pharmaceuticals, Inc. Ordinary Share (CASI).
- Disclosed ownership: 11%.
- Date of event: 30 Sep 2025.
Zhenfeng M. Chen - 30 Sep 2025 SCHEDULE 13G Report for CASI Pharmaceuticals, Inc. Ordinary Share (CASI)
- Filing Manager
- Zhenfeng M. Chen
- Reporting Manager
- Chen Zhenfeng
- Symbol
- CASI
- Shares outstanding
- 20,505,782 shares
- Disclosed Ownership
- 2,255,636 shares
- Ownership
- 11%
- Form type
- SCHEDULE 13G
- Filing time
- 26 Nov 2025, 16:05:26 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Zhenfeng M. Chen disclosed 11% ownership in CASI Pharmaceuticals, Inc. Ordinary Share (CASI) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 26 Nov 2025, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Chen Zhenfeng | 11% | 2,255,636 | 2,255,636 | 0 | /s/ Chen Zhenfeng | Chen Zhenfeng |